Abstract
Insulin-glucose infusion followed by intensive subcutaneous insulin in diabetic patients with acute myocardial infarction improves long term survival, and the effect seen at one year continues for at least 3.5 years, with an absolute reduction in mortality of 11%. This means that one life was saved for nine treated patients. The effect was most apparent in patients who had not previously received insulin treatment and who were at a low cardiovascular risk.
Keywords
MedicineInsulinDiabetes mellitusMyocardial infarctionInternal medicineRelative riskConfidence intervalEndocrinology
Affiliated Institutions
Related Publications
Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction
Background —The Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study addressed prognostic factors and the effects of concomitant treatment and gly...
Intensive Insulin Therapy in Critically Ill Patients
Intensive insulin therapy to maintain blood glucose at or below 110 mg per deciliter reduces morbidity and mortality among critically ill patients in the surgical intensive care...
Insulin Sensitivity and Insulin Binding to Monocytes in Maturity-Onset Diabetes
Tissue sensitive to insulin and insulin binding to monocytes were evaluated in 15 nonobese maturity-onset diabetics and in 16 healthy controls. Insulin sensitivity was determine...
Publication Info
- Year
- 1997
- Type
- article
- Volume
- 314
- Issue
- 7093
- Pages
- 1512-1512
- Citations
- 1299
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1299
OpenAlex
Cite This
K. Malmberg
(1997).
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus.
BMJ
, 314
(7093)
, 1512-1512.
https://doi.org/10.1136/bmj.314.7093.1512
Identifiers
- DOI
- 10.1136/bmj.314.7093.1512